ATE340188T1 - Transkriptionsfaktoren welche zwei potentielle dna bindende motive enthalten - Google Patents

Transkriptionsfaktoren welche zwei potentielle dna bindende motive enthalten

Info

Publication number
ATE340188T1
ATE340188T1 AT00977763T AT00977763T ATE340188T1 AT E340188 T1 ATE340188 T1 AT E340188T1 AT 00977763 T AT00977763 T AT 00977763T AT 00977763 T AT00977763 T AT 00977763T AT E340188 T1 ATE340188 T1 AT E340188T1
Authority
AT
Austria
Prior art keywords
contain
dna binding
transcription factors
potential dna
nucleic acid
Prior art date
Application number
AT00977763T
Other languages
English (en)
Inventor
Alison Banham
Jacqueline Loelia Cordell
Margaret Jones
Original Assignee
Isis Innovation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9928543.9A external-priority patent/GB9928543D0/en
Priority claimed from GB0017042A external-priority patent/GB0017042D0/en
Application filed by Isis Innovation filed Critical Isis Innovation
Application granted granted Critical
Publication of ATE340188T1 publication Critical patent/ATE340188T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/71Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/80Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT00977763T 1999-12-02 2000-12-01 Transkriptionsfaktoren welche zwei potentielle dna bindende motive enthalten ATE340188T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9928543.9A GB9928543D0 (en) 1999-12-02 1999-12-02 Novel transcription factors
GB0017042A GB0017042D0 (en) 2000-07-11 2000-07-11 Novel transcription factors

Publications (1)

Publication Number Publication Date
ATE340188T1 true ATE340188T1 (de) 2006-10-15

Family

ID=26244636

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00977763T ATE340188T1 (de) 1999-12-02 2000-12-01 Transkriptionsfaktoren welche zwei potentielle dna bindende motive enthalten

Country Status (9)

Country Link
US (1) US20030139330A1 (de)
EP (1) EP1246841B1 (de)
JP (1) JP2003515328A (de)
AT (1) ATE340188T1 (de)
AU (1) AU1539801A (de)
CA (1) CA2394996A1 (de)
DE (1) DE60030884T2 (de)
ES (1) ES2272336T3 (de)
WO (1) WO2001040303A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2003100422A1 (ja) * 2002-05-28 2005-09-29 株式会社ジェー・ジー・エス Dnaマイクロアレイデータ処理方法、dnaマイクロアレイデータ処理システム、dnaマイクロアレイデータ処理装置、プログラム、および、記録媒体
WO2005095447A2 (en) * 2004-03-29 2005-10-13 Isis Innovation Limited Low molecular weight forms of foxp1 proteins and splice variants thereof
ATE459720T1 (de) * 2004-08-18 2010-03-15 Bayer Cropscience Ag Pflanzen mit erhöhter plastidär aktivität der stärkephosphorylierenden r3-enzyme
CA2752947A1 (en) * 2011-06-30 2012-12-30 Benjamin J. Blencowe Foxp1 splice variants and methods and uses thereof
WO2013063019A1 (en) 2011-10-28 2013-05-02 The Wistar Institute Of Anatomy And Biology Methods and compositions for enhancing the therapeutic effect of anti-tumor t cells
WO2017176380A1 (en) 2016-02-22 2017-10-12 The General Hospital Corporation Systems and methods for selective targeting of structural features in treating skin conditions
WO2022067230A1 (en) * 2020-09-28 2022-03-31 The Research Institute At Nationwide Children's Hospital Identification of pax3-foxo1 binding genomic regions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19820190A1 (de) * 1998-04-28 1999-11-04 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Pankreas-Tumor

Also Published As

Publication number Publication date
DE60030884T2 (de) 2007-04-26
ES2272336T3 (es) 2007-05-01
EP1246841B1 (de) 2006-09-20
EP1246841A1 (de) 2002-10-09
AU1539801A (en) 2001-06-12
CA2394996A1 (en) 2001-06-07
DE60030884D1 (de) 2006-11-02
US20030139330A1 (en) 2003-07-24
JP2003515328A (ja) 2003-05-07
WO2001040303A1 (en) 2001-06-07

Similar Documents

Publication Publication Date Title
DE69831224D1 (de) Immuntoxine, die ein onc protein enthalten, gegen bösartige zellen
NO961812D0 (no) Humanproteaseinhibitorer av Kunitz-type
ATE354675T1 (de) Dna-protein fusionen sowie anwendungen derselben
DE69013520D1 (de) Stabile integration von dna in bakterielle genome.
DE69942861D1 (de) Ldcam genannte moleküle
WO2003062455A3 (en) Zinc finger domain recognition code and uses thereof
EP0770129A4 (de) Derivate von zinkfingerproteinen und methoden
FI964808A0 (fi) Puhdistetut Myceliophthora lakkaasit ja niitä koodaavat nukleiinihapot
DE69840413D1 (de) Dna 19355 polypeptide, ein homolog des tumornekrosefaktors
TR200002989T2 (tr) Heliomisin için gen kodu ve bunun kullanılması.
ATE350472T1 (de) Jmy, mit-aktivator für p300/cbp, dafür kodierendenucleinsäure und deren verwendungen
ATE340188T1 (de) Transkriptionsfaktoren welche zwei potentielle dna bindende motive enthalten
ATE340257T1 (de) Histonedeacetylase 9
HUT77029A (hu) A GAP-protein SH3 doménjéhez kötődni képes peptidek, ezeket kódoló nukleotidszekvenciák és előállításuk és alkalmazásuk
ATE427959T1 (de) Gereinigtes sr-p70 protein
ATE441712T1 (de) Die nukleotidsequenz ann bindende zink-finger domänen
EP0809103A3 (de) Stabile Denaturierungsmittel für elektroforetische Techniken und dafür geeignete Verfahren
AU2001249929A1 (en) Fdrg proteins and nucleic acid molecules and uses therefor
CA2287902A1 (en) Isolated nucleic acid molecules encoding ssx family members and uses thereof
Jones The terminology of guanidine formation
WO2004034093A3 (en) Caterpiller gene family
KR960010861A (ko) 사람 전사 인자 iiia 유전자
WO2003062447A3 (en) Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
ATE393224T1 (de) Nukleinsäuresequenzen von hyperplasien und tumoren der schilddrüse
AU4826899A (en) Novel msp-5 protein and nucleic acid molecules and uses therefor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties